| abstract |
Methods of inducing formation of functional and organized lymphatic vessels are described. Specifically, the methods relate to using Tie2 a agonists to induce formation of functional and organized lymphatic vessels. The methods also relate to treating defects, diseases, and disorders characterized by lymphatic vessel malfunction, disorganization, and damage. |